Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

EVEREST MED

57.200
+0.9501.69%
Volume:5.47M
Turnover:309.25M
Market Cap:18.70B
PE:-16.10
High:57.700
Open:56.700
Low:54.950
Close:56.250
Loading ...
OverviewCompanyNewsFilings

Concept

Nonprofit Pharmaceutical Companies-2.33%
Hillhouse Capital Related-1.18%

Capital Flow

 
Inflow:
 
Outflow:
 
 
 
 
 
 
 
 
 
 
 
 
 
 

News

Everest Medicines Ltd. Conducted Annual General Meeting

Reuters
·
Yesterday

BRIEF-Everest Medicines Says Exec Director & CEO Not Disposed Of Any Shares

Reuters
·
13 Jun

Everest Medicines Ltd. Announces Positive Results from Phase 1b/2a Trial for EVER001 in Treating Primary Membranous Nephropathy

Reuters
·
13 Jun

Everest Medicines Ltd - Executive Director and Chief Executive Officer, Others Not Disposed of Any Shares

THOMSON REUTERS
·
13 Jun

Analyst Rate

Buy
Buy
42.86%
Hold
57.14%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Mar 26, 2025
Financial Report Announcement
Aug 27, 2024 Post Market
Financial Report Announcement
Mar 28, 2024
Financial Report Announcement
Aug 24, 2023
Financial Report Announcement
Mar 30, 2023

Dividend History

no data

No relevant data is available

Valuation Analysis

-16.29
Current
-475.09
Sector Average
28.26%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-16.29
Maximum
-0.86
+1 STD
413.28
Minimum
-2,939.11
-1 STD
-1,363.46
Average
-475.09

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.